DCM
PAHC icon

Davis Capital Management’s Phibro Animal Health PAHC Stock Holding History

Davis Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31 Buy
+1
New +$42 ﹤0.01% 1260

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Davis Capital Management's PAHC Position: Q2 2026 in Review

Davis Capital Management opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 1 share worth $31. The stake represents ﹤0.01% of the portfolio and ranks #1260 among its holdings.

208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Davis Capital Management held 1 share of Phibro Animal Health worth $31 as of Q2 2026.
  • Phibro Animal Health was a new Davis Capital Management position in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1260 holding.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.